Tomoyoshi Takenaka

Tomoyoshi Takenaka

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications

M1C IS NECESSARY FOR DARAXONRASIB RESISTANCE OF NSCLC KRAS(G12C) MUTANT CELLS.

M1C IS NECESSARY FOR DARAXONRASIB RESISTANCE OF NSCLC KRAS(G12C) MUTANT CELLS.

Journal: bioRxiv : the preprint server for biology
Published: July 08, 2026

Radiofrequency Identification Marker-Guided Right S7 Segmentectomy for a Deeply Located Pulmonary Nodule: A Case Report.

Radiofrequency Identification Marker-Guided Right S7 Segmentectomy for a Deeply Located Pulmonary Nodule: A Case Report.

Journal: Surgical case reports
Published: April 30, 2026

Comparison of RATS Lobectomy and VATS Lobectomy for Early-stage Non-small Cell Lung Cancer.

Comparison of RATS Lobectomy and VATS Lobectomy for Early-stage Non-small Cell Lung Cancer.

Journal: Anticancer research
Published: March 29, 2026

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Journal: Annals of surgical oncology
Published: March 25, 2026

Fibrotic Interstitial Lung Abnormalities on Preoperative CT Images Predict Cause-Specific Mortality after Stage I Non-Small Cell Lung Cancer Resection.

Fibrotic Interstitial Lung Abnormalities on Preoperative CT Images Predict Cause-Specific Mortality after Stage I Non-Small Cell Lung Cancer Resection.

Journal: Annals of surgical oncology
Published: March 20, 2026

M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.

M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.

Journal: Oncogene
Published: March 05, 2026

ASO Author Reflections: The Emerging Role of the CALLY Index in Surgically Resected Non-Small-Cell Lung Cancer.

ASO Author Reflections: The Emerging Role of the CALLY Index in Surgically Resected Non-Small-Cell Lung Cancer.

Journal: Annals of surgical oncology
Published: November 07, 2025

Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone.

Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone.

Journal: International cancer conference journal
Published: November 01, 2025

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.

Journal: Signal transduction and targeted therapy
Published: September 27, 2025

Safe Resection of a Giant Mediastinal Liposarcoma with Severe Cardiac Compression.

Safe Resection of a Giant Mediastinal Liposarcoma with Severe Cardiac Compression.

Journal: Surgical case reports
Published: September 11, 2025

Prognostic Impact of Preoperative Osteopenia for Patients with Resected Non-Small Cell Lung Cancer.

Prognostic Impact of Preoperative Osteopenia for Patients with Resected Non-Small Cell Lung Cancer.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: September 05, 2025

Surgical resection of an adrenocorticotropic hormone-producing pulmonary typical carcinoid with mediastinal lymph node metastasis and high programmed death-ligand 1 expression.

Surgical resection of an adrenocorticotropic hormone-producing pulmonary typical carcinoid with mediastinal lymph node metastasis and high programmed death-ligand 1 expression.

Journal: International cancer conference journal
Published: August 09, 2025
Showing 1-12 of 131

Last Updated: 09/26/2026